Fiber for synthetic grass field

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Tarkett Inc. patent solves the following problem:

Artificial grass fields (artificial turf) used for years to provide a surface that simulates natural grass. These artificial grass field there are many benefits to natural grass, and, moreover, can be installed and used in places that do not allow for natural grass fields.

Our analysis of this patent is as follows:

Tarkett Inc.’s patent US 9005723 B2 deals with Fiber for synthetic grass field.
A filament for use in an artificial grass field, where the filament has a front and a rear face and at least one of the front face and rear face includes a number of neighboring concave indentations gave general -from a first end to a second end.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Aligning segments of bar graphs for comparative analysis

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Domo, Inc. patent solves the following problem:

Our analysis of this patent is as follows:

Domo, Inc.’s patent US 8914740 B1 deals with Aligning segments of bar graphs for comparative analysis.
A user interface for allowing a user to interact with a graphical display, to conduct a comparative look at the display elements. A bar graph or other quantitative display is provided, wherein each bar is divided into a plurality of parts. Responsive to user input, for a given species, in different bars, realigned one another along a common baseline, so that the area can be more easily compared to a a. At least one photo, the realignment passes, and the original graph restored upon further user input and / or after a predetermined period of time.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Process for making particles for delivery of drug nanoparticles

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Nanomaterials Technology Pte Ltd patent solves the following problem:

Artificial or natural drugs aim to serve as a cure or preventive agents for diseases and may be administered to the body by methods such as injection or ingestion. In comparing the different routes of drug administration is, ingestion or oral administration is preferred as it is less painful and have a higher rate of patient compliance. It is also a more convenient and simple or uncomplicated manner as compared to injection.

Our analysis of this patent is as follows:

Nanomaterials Technology Pte Ltd’s patent US 8835376 B2 deals with Process for making particles for delivery of drug nanoparticles.
A process for making the particles to deliver drug nanoparticles is revealed here. The process comprises the steps of (a) forming a suspension of drug nanoparticles by mixing a precipitant solution with an anti-solvent solution under micro-mixing environment, which formed nanoparticles with a narrow particle size distribution; (B) to provide an excipient at least one of the precipitant solution, the anti-solvent solution and the suspension of nanoparticles drug, the excipient selected to continue in the said drug nanoparticles in a scattered state when in liquid form; and (c) drying the suspension of nanoparticles drug containing the excipient therein to remove solvent, wherein the removal of the excipient may cause the strengthening and thus forming micro-sized matrix particles, each micro-sized particle containing drug nanoparticles dispersed in a solid matrix excipient.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Drag reducing apparatus for a vehicle

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Aerodynamic Trailer Systems, Llc patent solves the following problem:

The present invention is a division of US application Ser. No. 12 / 594,662 at December 23, 2009, which in turn claims priority to US Provisional Patent Application Ser. No. 60 / 907,554 and May 5, 2007, and PCT / US08 / 059382 and May 4, 2008, incorporated here by reference.

Our analysis of this patent is as follows:

Aerodynamic Trailer Systems, Llc’s patent US 8622462 B2 deals with Drag reducing apparatus for a vehicle.
exposure consisted of a pair of inflatable substantially inelastic lobes. A claim can be mounted on each of the rear trailer door with a standard tractor-trailer unit. Each lobe can be inflated or deployed to give a flying substantially planar contour extending rearwardly back end of the car. The flying form lobes with strong and substantially planar outer surface for the wind up will be done in a series of internal rope and flag set extending substantially horizontally and vertically in a forest from a chasing side to the other side of each sheet. When the lobes shrink, the trailer door can be opened and decided on the side of the trailer in a conventional manner.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Secreted proteins

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Incyte Corporation patent solves the following problem:

Protein transport and secretion is necessary for cellular function. Transport protein mediated a signal peptide located at amino terminal protein dad or hidden. The signal peptide consists of ten to twenty hydrophobic amino acids that target the nascent protein from ribosome to a particular membrane bound compartment such as the endoplasmic reticulum (ER). Protein target the ER to continue by way secretory or stay in any of the secretory organelles such as the ER, Golgi apparatus, or lysosomes. Proteins that transit through the secretory way be secreted into the extracellular space or left in the plasma membrane. Protein retained in the plasma membrane includes one or more transmembrane domains, each consisting of 20 hydrophobic amino acid residues. Secreted protein normally synthesized as inactive precursors because of the post-translation processing events during transit through the secretory way. Such events include glycosylation, proteolysis, and removal of the signal peptide with a signal peptidase. The other events that occur during the transport proteins include chaperone-dependent expression and folding of nascent proteins and protein interaction with a receptor or pore complex. Examples of secreted proteins with amino terminal signal peptide described below and include protein with an important role in cell-to-cell signaling. Such proteins include transmembrane receptor and cell surface markers, extracellular matrix molecules, cytokines, hormones, growth and diversity factor, enzyme, neuropeptides, vasomediators, cell surface markers, and antigen recognition molecules. (Reviewed in Alberts, B. et al. (1994) Molecular Biology of the Cell, garland Publishing, New York, NY, pp. 557-560, 582-592.)

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 8569445 B2 deals with Secreted proteins.
human invention provides secreted protein (SECP) and polynucleotides which identify and encode SECP. invention also provides expression vector, host cells, antibodies, agonists and antagonists. invention also provides methods for diagnosing, treating, or preventing diseases associated with aberrant expression of SECP.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nutritional formula for optimal gut barrier function

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Nestec S.A. patent solves the following problem:

The present invention relates to a composition for inducing a pattern of gut barrier maturation similar to that found in breast feeding and able to improve gut barrier maturation, eg during neonatal stress. In particular, the present invention relates to a formula containing a combination of certain ingredients that are designed to provide a synergistic effect all along the gastrointestinal tract and barrier function.

Our analysis of this patent is as follows:

Nestec S.A.’s patent US 8394370 B2 deals with Nutritional formula for optimal gut barrier function.
The present invention relates to a composition for inducing a pattern of gut barrier maturation similar to that found in breast-feeding and able to improve gut barrier maturation, eg during neonatal stress. In particular, the present invention relates to a formula containing a combination of certain ingredients that are designed to provide a synergistic effect all along the gastrointestinal tract and barrier function.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Human -adrenergic receptor kinase polypeptide and methods

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Incyte Corporation patent solves the following problem:

Change protein phosphorylation is ubiquitous methods used to control many of intracellular events in eukaryotic cells. It is estimated that more than ten percent of the active protein in a typical mammal cell are phosphorylated. Kinases to facilitate the transfer of high-energy phosphate group from adenosine triphosphate (ATP) to the target protein hydroxyamino acid residues serine, threonine, or tyrosine. Phosphatases, in contrast, take the phosphate groups. Extracellular signal including hormone; neurotransmitter, growth and inequality factors may activate kinases, which takes place as the cell surface of cells or as activator in the final effector proteins, as well as other places along the way signal transduction. Cascade of kinases occur, as well as sensitive kinases second messenger molecules. This system allows for equipment to amplify the weak signal (lower abundance of growth factor molecules, for example), as well as the synthesis of many weak signal into an all-or-nothing answer. Phosphatases, then, is necessary to determine the extent of phosphorylation in cells and, with kinases, controlling key cellular processes such as metabolic enzyme activity, proliferation, cell growth and inequality, cell adhesion, and cell cycle progression.

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 8263378 B2 deals with Human -adrenergic receptor kinase polypeptide and methods.
Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also giving expression vector, host cells, antibodies, agonists and antagonists. Some embodiments provide methods for diagnosing, treating, or preventing diseases associated with aberrant expression of KPP.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Consumable holder with converter

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Whirlpool Corporation patent solves the following problem:

The invention relates to devices that hold consumables used or operated by a communication tool.

Our analysis of this patent is as follows:

Whirlpool Corporation’s patent US 8264318 B2 deals with Consumable holder with converter.
A consumable holder provided for use in an appliance configured to perform an operation cycle related to a consumable consumable holder. The consumable holders are able to obtain information relating to himself or consumable, and further includes a converter configured to transform the information into a cycle structure. Therefore, the consumable holder communicate with one engine cycle to create or change a cycle structure for using the appliance to perform an operation cycle related consumable.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Devices and methods for reducing vehicle drag

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Henderson Industries, Llc patent solves the following problem:

An ongoing effort to reduce the drag in vehicular structures is of great importance as the fuel economy will be a greater consideration in vehicular design. As the drag of a car increases, the amount of fuel needed to move vehicles also increased because of greater energy required to overcome drag. For example, it states that for a vehicle traveling at 70 mph, 65% of the total fuel consumption of the engine of the car used to overcome drag. Therefore, even a small reduction in drag experienced by a vehicle traveling at a speed of course would result in a significant improvement in fuel economy.

Our analysis of this patent is as follows:

Henderson Industries, Llc’s patent US 8251436 B2 deals with Devices and methods for reducing vehicle drag.
A car trailer is given. The car trailer includes a pair of side wall fairings with a leading edge and trailing edge. Each side wall fairing located on a different wall from the other side of the rear edge of each of the wall so that the top edge of each side wall fairing contact with the wall, and the trailing edge of each side wall fairing not contact the wall. Each side wall fairing has an upward slope and down slope. The side wall fairings can be used in one or more other components described here.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nutrition with lipids and non-digestible saccharides

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The N. V. Nutricia patent solves the following problem:

The gut barrier lines in the gastro-intestinal tract and separates the luminal, outside of the body from the systemic, internal organ. It protects the body from entering the luminal enemies, such as antigens, toxins and pathogens. The gut barrier consists of intestinal epithelium, a continuous monolayer pillars of epithelial cells, enterocytes, bound by protein complexes, such as tight junctions. A tenuous gut barrier function in children, where the gut before maturated enough. Also malnourished people, the patients fasted for surgery and intensive care patients the gut barrier disrupted.

Our analysis of this patent is as follows:

N. V. Nutricia’s patent US 8241659 B2 deals with Nutrition with lipids and non-digestible saccharides.
The invention relates to a liquid nutrition containing short chain fatty acyl chains and a non-digestible, give a saccharide. composition is particularly suitable for use as a child nutrition. composition is suitable for the treatment and / or prevention of gut barrier related diseases.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.